Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Agne Sadauskaite"'
Autor:
Stergios Boussios, Peeter Karihtala, Michele Moschetta, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy, Nicholas Pavlidis
Publikováno v:
Diagnostics, Vol 9, Iss 3, p 87 (2019)
Poly (ADP-ribose) polymerase (PARP) inhibitors are the first clinically approved drugs designed to exploit synthetic lethality, and were first introduced as a cancer-targeting strategy in 2005. They have led to a major change in the treatment of adva
Externí odkaz:
https://doaj.org/article/17279f479d6a438fb867fdf6bbfad125
Autor:
Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, Cherie Neille, Agne Sadauskaite, Michele Moschetta, Nikolaos Zakynthinakis-Kyriakou, Nicholas Pavlidis
Publikováno v:
Diagnostics, Vol 9, Iss 2, p 55 (2019)
Poly (ADP-ribose) polymerase (PARP) inhibitors are a novel class of therapeutic agents that target tumors with deficiencies in the homologous recombination DNA repair pathway. Genomic instability characterizes high-grade serous ovarian cancer (HGSOC)
Externí odkaz:
https://doaj.org/article/555c822c7723436e99dc6ed3dea5e361
Autor:
Matin Sheriff, Christos Mikropoulos, Stergios Boussios, Elie El Rassy, Peeter Karihtala, Afroditi Karathanasi, Agne Sadauskaite, Eleftherios P. Samartzis, Nicholas Pavlidis, Michele Moschetta
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 10, Iss 41, p 41 (2020)
Journal of Personalized Medicine, Vol 10, Iss 41, p 41 (2020)
Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women. Two-thirds of patients present at advanced stage at diagnosis, and the estimated 5 year survival rate is 20–40%. This heterogeneous group of malignancies ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1f3b9243a8c5b4e1b5d7302e9220c8
https://www.repository.cam.ac.uk/handle/1810/305714
https://www.repository.cam.ac.uk/handle/1810/305714
Autor:
Elie El Rassy, Afroditi Karathanasi, Peeter Karihtala, Nicholas Pavlidis, Stergios Boussios, Michele Moschetta, Agne Sadauskaite
Publikováno v:
Diagnostics, Vol 9, Iss 3, p 87 (2019)
Diagnostics
Diagnostics
Poly (ADP-ribose) polymerase (PARP) inhibitors are the first clinically approved drugs designed to exploit synthetic lethality, and were first introduced as a cancer-targeting strategy in 2005. They have led to a major change in the treatment of adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2a840d9140913f01eb08e0cac5b570a
https://www.mdpi.com/2075-4418/9/3/87
https://www.mdpi.com/2075-4418/9/3/87
Autor:
Stergios Boussios, Agne Sadauskaite, Konstantinos H. Katsanos, Nicholas Pavlidis, Eleftherios P. Samartzis, Elie El Rassy, Matin Sheriff, Michele Moschetta, Rachel Hallit, Dimitrios K. Christodoulou
Publikováno v:
Ann Transl Med
Vaccines, cytokines, and adoptive cellular therapies (ACT) represent immuno-therapeutic modalities with great development potential, and they are currently approved for the treatment of a limited number of advanced malignancies. The most up-to-date k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9f16aa475723456c5570ac6e8edd85d
https://doi.org/10.21037/atm-20-7361
https://doi.org/10.21037/atm-20-7361
Autor:
Stergios Boussios, Matin Sheriff, Alexandros K. Tsiouris, Afroditi Karathanasi, Foivos S. Kanellos, Agne Sadauskaite
Publikováno v:
Gynecology and Pelvic Medicine. 3:19-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f41e5f710da1bdf66123fe3c19818c9
https://doi.org/10.21037/gpm-20-41
https://doi.org/10.21037/gpm-20-41